Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
| Conditions: | Tumor |
| Start Date: | September 1, 2005 |
| Phase: | Phase I |
| Status: | Completed |
| NCT ID: | NCT00413322 |
| Study Type: | Interventional |
| Intervention: | Drug: belinostat|Drug: 5-Fluorouracil (5-FU) |
| Study Design: | Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | TopoTarget A/S |
| Ages: | Adult|Senior |
| Enrollment: | 35 |
| Funded By: | Industry |
| First Received: | December 18, 2006 |
| End Date: | June 1, 2008 |
| Last Updated: | March 31, 2009 |
| Last Verified: | March 1, 2009 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
